ADL Bionatur Solutions announced the signing of a new contract with a leading Swiss biotechnology company for the production of two novel products. The contract, which has an initial duration of 7 years, utilizes ADL's expertise in technology transfer and upscaling and includes the industrial-scale supply of two innovative ingredients for use in cosmetics and nutrition products. Related revenues total an estimated EUR 20 million over the duration of the contract. This agreement further strengthens ADL's position as a strong European player in fermentation, with renowned expertise in scale-up and industrial-scale supply of fermented products. Long-term partnerships reflect the reliability and trust in ADL as an international partner of choice for the development and delivery of novel products by innovative processes such as multi-product fermentation. Both companies agreed to immediately initiate the technology transfer for the first product and expect the transfer to be completed in the beginning of 2020. Scale-up and industrial-scale production activities will start afterwards. The agreement supports the strong growth of ADL's CMO (contract manufacturing organization) business division, which accounted for 71% of total revenues for the first half of 2019. For the next two years, over 85% of available fermentation capacity has already been committed, a clear indicator of the Company's continued strong growth potential and business strategy. The CMO services are carried out at ADL's site in León, Spain, the fermentation facility in southern Europe available to third parties, with a current capacity of 2,400 m3. ADL is one of the main suppliers of innovative products manufactured by fermentation for several multinational companies.